Skip to main content
. 2014 Dec;5(6):408–413. doi: 10.3978/j.issn.2078-6891.2014.072

Figure 2.

Figure 2

PFS Kaplan Meier for four second line systemic groups. PFS, progression-free survival. GEM-FU, gemcitabine plus fluoropyrimidine; GEM-P, gemcitabine plus platinum; FU-combo, fluoropyrimidine combination.